Table 4 Subgroup characteristics of patients with pathological pepsinogen test
From: Serological assessment of gastric mucosal atrophy in gastric cancer
|  |  | PG1 < 70 μg/ml |  | PG1/2-ratio < 3.0 |  | ||
|---|---|---|---|---|---|---|---|
| Â | Â | Positive (n = 47) | Negative (n = 71) | p-value | Positive (n = 20) | Negative (n = 98) | p-value |
Laurén type | Intestinal | 28 (59.6%) | 31 (43.7%) | n.s. | 14 (70%) | 45 (45.9%) | n.s. |
| Â | Diffuse | 19 (40.4%) | 40 (56.3%) | Â | 6 (30%) | 53 (54.1%) | Â |
Localisation | Proximal | 19 (40.4%) | 34 (47.9%) | n.s. | 11 (55%) | 42 (42.9%) | n.s. |
| Â | Distal | 28 (59.6%) | 37 (52.1%) | Â | 9 (45%) | 56 (57.1%) | Â |
H. pylori | (positive) | 40 (85.1%) | 59 (83.1%) | n.s. | 17 (85%) | 82 (83.7%) | n.s. |
CagA | (positive) | 34 (72.3%) | 43 (60.6%) | n.s. | 15 (75%) | 62 (63.3%) | n.s. |
IM | (positive) | 39 (83.0%) | 47 (66.2%) | 0.057 | 16 (80%) | 70 (71.4%) | n.s. |
Atrophy* | (positive) | 25 (53.2%) | 18 (25.4%) | 0.003 | 12 (60%) | 31 (31.6%) | 0.022 |